Semaglutide
STEP UP
Novo Nordisk · Phase 3 · Completed · Enrollment 1407
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide 7.2 mg | n/r | n/r | n/r | 5.4% | n/r |
| Semaglutide 2.4 mg | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | 1% | n/r |
A count stays a count. This page does not turn a count into a percent.